Dr Reddy’s Mexico API facility receives two FDA observations
Dr Reddy’s said the US FDA completed a records assessment at its Mexico API manufacturing facility and issued two observations.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.